Cite
Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses.
MLA
Kment, Jacob, et al. “Blockade of TGF-β and PD-L1 by Bintrafusp Alfa Promotes Survival in Preclinical Ovarian Cancer Models by Promoting T Effector and NK Cell Responses.” British Journal of Cancer, vol. 130, no. 12, June 2024, pp. 2003–15. EBSCOhost, https://doi.org/10.1038/s41416-024-02677-9.
APA
Kment, J., Newsted, D., Young, S., Vermeulen, M. C., Laight, B. J., Greer, P. A., Lan, Y., & Craig, A. W. (2024). Blockade of TGF-β and PD-L1 by bintrafusp alfa promotes survival in preclinical ovarian cancer models by promoting T effector and NK cell responses. British Journal of Cancer, 130(12), 2003–2015. https://doi.org/10.1038/s41416-024-02677-9
Chicago
Kment, Jacob, Daniel Newsted, Stephanie Young, Michael C. Vermeulen, Brian J. Laight, Peter A. Greer, Yan Lan, and Andrew W. Craig. 2024. “Blockade of TGF-β and PD-L1 by Bintrafusp Alfa Promotes Survival in Preclinical Ovarian Cancer Models by Promoting T Effector and NK Cell Responses.” British Journal of Cancer 130 (12): 2003–15. doi:10.1038/s41416-024-02677-9.